Cargando…

Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell

Gankyrin is an ankyrin-repeat oncoprotein whose overexpression has been implicated in the development of many cancer types. Elevated gankyrin levels are linked to aberrant cellular events including enhanced degradation of tumour suppressor protein p53, and inhibition of gankyrin activity has therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chattopadhyay, Anasuya, O’Connor, Cornelius J., Zhang, Fengzhi, Galvagnion, Celine, Galloway, Warren R. J. D., Tan, Yaw Sing, Stokes, Jamie E., Rahman, Taufiq, Verma, Chandra, Spring, David R., Itzhaki, Laura S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820706/ https://www.ncbi.nlm.nih.gov/pubmed/27046077 http://dx.doi.org/10.1038/srep23732

Ejemplares similares

Resurfaced Shape Complementary Proteins That Selectively Bind the Oncoprotein Gankyrin
por: Chapman, Alex M., et al.
Publicado: (2014)

Identification of a covalent binder to the oncoprotein gankyrin using a NIR-Based OBOC screening method
por: Maresh, Marianne E., et al.
Publicado: (2021)

Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and Metastasis
por: Luo, Xue, et al.
Publicado: (2012)

Characterization of the Binding Interaction between the Oncoprotein Gankyrin and a Grafted S6 ATPase
por: Chapman, Alex M., et al.
Publicado: (2014)

The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Effects of Ligand Binding on the Mechanical Properties of Ankyrin Repeat Protein Gankyrin
por: Settanni, Giovanni, et al.
Publicado: (2013)

Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma
por: Wang, Chongchong, et al.
Publicado: (2021)

Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
por: Wang, Chengxing, et al.
Publicado: (2021)

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014)

Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation
por: D’Souza, Amber M., et al.
Publicado: (2018)

Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance
por: Jing, Hongbiao, et al.
Publicado: (2014)

Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
por: D’Souza, Amber M., et al.
Publicado: (2022)

Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin
por: Kashyap, Dharmendra, et al.
Publicado: (2021)

Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis
por: Liu, Yuan, et al.
Publicado: (2014)

Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma
por: Yang, Chun, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis
por: Zhao, Xiaotong, et al.
Publicado: (2016)

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2018)

LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients
por: Guo, Xu, et al.
Publicado: (2020)

The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells
por: Camacho-Moll, Maria E., et al.
Publicado: (2019)

Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma
por: Yang, Chun, et al.
Publicado: (2022)

Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota
por: Sakurai, Toshiharu, et al.
Publicado: (2020)

Role of a 19S Proteasome Subunit- PSMD10(Gankyrin) in Neurogenesis of Human Neural Progenitor Cells
por: Sahu, Indrajit, et al.
Publicado: (2019)

LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway
por: Song, Xuan, et al.
Publicado: (2013)

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
por: Zhao, X, et al.
Publicado: (2015)

Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
por: Sun, Ying, et al.
Publicado: (2018)

The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin
por: Xu, Xiaoliang, et al.
Publicado: (2019)

Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation
por: Huang, Bo, et al.
Publicado: (2018)

Evidence that Proteasome-Dependent Degradation of the Retinoblastoma Protein in Cells Lacking A-Type Lamins Occurs Independently of Gankyrin and MDM2
por: Nitta, Ryan T., et al.
Publicado: (2007)

Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner
por: Yu, Tong, et al.
Publicado: (2022)

Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression
por: He, Feng, et al.
Publicado: (2016)

Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance
por: Peng, Guang, et al.
Publicado: (2023)

Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin
por: D’Souza, Amber M., et al.
Publicado: (2021)

Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase
por: Xu, Wenshu, et al.
Publicado: (2017)

KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling
por: Han, Jihua, et al.
Publicado: (2018)

Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2020)

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2
por: Yadahalli, Shilpa, et al.
Publicado: (2019)

Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
por: Wang, Wu-ping, et al.
Publicado: (2016)

Bu Shen Yang Xue Prescription Has Treating Effect on Endometrial Cancer through FSH/PI3K/AKT/Gankyrin/HIF-α/cyclinD 1 Pathway in Ishikawa Cells
por: Chen, Yue-qun, et al.
Publicado: (2018)

Development of Cell‐Permeable, Non‐Helical Constrained Peptides to Target a Key Protein–Protein Interaction in Ovarian Cancer
por: Wiedmann, Mareike M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_co7b37eo85ri50qlbbtpvnqeed